MUHC Glen Site Cedars Cancer Centre

Montreal, Quebec H4A 3J1

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Higher-Risk Myelodysplastic Syndrome (HR-MDS), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Newly Diagnosed Intermediate/High-Risk MDS, Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Relapsed/Refractory Multiple Myeloma (RRMM)

Studies at this site

• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma — Completed